1. He, Jingjing, Zhang, Meng, Ren, Jianhua, Jiang, Xiaolian. 2024. Correlation between TCF7L2 and CAPN10 gene polymorphisms and gestational diabetes mellitus in different geographical regions: a meta-analysis. In BMC pregnancy and childbirth, 24, 15. doi:10.1186/s12884-023-06177-1. https://pubmed.ncbi.nlm.nih.gov/38166877/
2. Rattanatham, Rujikorn, Settasatian, Nongnuch, Komanasin, Nantarat, Senthong, Vichai, Settasatian, Chatri. 2021. Association of Combined TCF7L2 and KCNQ1 Gene Polymorphisms with Diabetic Micro- and Macrovascular Complications in Type 2 Diabetes Mellitus. In Diabetes & metabolism journal, 45, 578-593. doi:10.4093/dmj.2020.0101. https://pubmed.ncbi.nlm.nih.gov/33752320/
3. Brown, Markus A, Dotson, Gabrielle A, Ronquist, Scott, Rajapakse, Indika, Ried, Thomas. 2021. TCF7L2 silencing results in altered gene expression patterns accompanied by local genomic reorganization. In Neoplasia (New York, N.Y.), 23, 257-269. doi:10.1016/j.neo.2020.12.010. https://pubmed.ncbi.nlm.nih.gov/33422939/
4. Ozkan Kucuk, Nazlı Ezgi, Horozoglu, Cem, Timirci Kahraman, Ozlem, Sabitaliyevich, Uteuliyev Yerzhan, Yaylim, Ilhan. 2019. Gene variants of TCF7L2 are histopathologically important in colorectal cancers but do not have direct association with MYC expression. In Cellular and molecular biology (Noisy-le-Grand, France), 65, 1-6. doi:. https://pubmed.ncbi.nlm.nih.gov/32133972/
5. Florez, Jose C. . The new type 2 diabetes gene TCF7L2. In Current opinion in clinical nutrition and metabolic care, 10, 391-6. doi:. https://pubmed.ncbi.nlm.nih.gov/17563454/